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OBSERVATIONS
Cardiometabolic
Risk in a Rural
Ugandan
Population
A lthoughmany studies have examinedmetabolic syndrome (MetS) and theFramingham Risk Score (FRS), few
studies have been carried out in African
populations. This limited information on
MetS and FRS leaves us with an incomplete
understanding of the prevalence and dis-
tribution of risk of cardiometabolic disease
in sub-Saharan Africa (SSA). It also pre-
vents us from critically evaluating how each
of the varying deﬁnitions ofMetS compares
in African populations. A clearer under-
standing of MetS and FRS in African
populationsmayprovide the basis for better
identifying the impact of these deﬁnitions
and tools on disease risk and, furthermore,
help to evaluate the usefulness of such tools
for research and for informing public health
care and prevention policy in SSA.
In this study, we examined the prev-
alence and distribution of MetS and high
(.20%) FRS and compare the World
Health Organization (WHO), Adult Treat-
ment Panel (ATP) III, International Diabetes
Federation (IDF), and the newly proposed
harmonized deﬁnitions of MetS in a rural
Ugandan population (1). A total of 8,087
participants, aged 13 years and older, were
surveyed, of whom 7,423 (55% women)
had complete data for analysis. Data were
collected using standard procedures, and
prediabetes was deﬁned using HbA1c
$5.7% ($39 mmol/mol) (2).
The prevalence of MetS varied by de-
ﬁnition used, with the WHO, ATPIII, IDF,
and harmonized deﬁnitions resulting in
MetS prevalence of 4.1%, 9.9%, 8.9%, and
13.7%, respectively. The harmonized def-
inition was the most sensitive, capturing
all those identiﬁed using ATPIII and IDF
and 85.4% of those identiﬁed using the
WHO criteria. MetS increased with age
(P value , 0.001), with a distinctive peak
in the prevalence at ages 50–59 years for
men for all deﬁnitions.
The age-standardized prevalence of
MetS, for all deﬁnitions, was higher in
women (5.0% [95% CI 4.3–5.6] to 18.6%
[95% CI 17.5–19.7]) than men (1.1%
[95% CI 0.7–1.5] to 7.0% [95% CI 6.1–
7.9]). The largest difference in MetS preva-
lence between men and women (1.1%
[95% CI 0.7–1.5] vs. 14.5% [95% CI
13.5–15.6]) was found for the IDF deﬁni-
tion. This was likely due to the substantial
sex difference in central obesity (1.6%
[95% CI 1.2–2.0] in men versus 29.7%
[95% CI 28.4–31.0] in women), which is
required in the IDF deﬁnition of MetS.
Since there is no validated waist circumfer-
ence cutoff for Africans, the IDF deﬁnition
may currently be inappropriate for African
populations (3).
The mean value of FRS was 3.30 (SD
6.5), with 3.5% having high FRS. Only 8–
28%, depending on the MetS deﬁnition,
had both MetS and high FRS. By contrast
to MetS, high FRS was more common
among men (5.8% [95% CI 5.1–6.5])
than women (1.9% [95% CI 1.5–2.3]).
High FRS increased with age (P value ,
0.001).
We found marked differences in the
prevalence and distribution of cardiome-
tabolic disease risk according to FRS and
MetS deﬁnitions in this rural Ugandan
population. These inconsistencies empha-
size the need to more reliably assess the
impact of these risk classiﬁcations in SSA
populations. Prospective observational
studies will be essential to evaluate and
assess the distribution and determinants of
cardiometabolic disease risk and to help to
inform policy and health care programs in
SSA (4).
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